Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
Unusual Whales
A Phase 2 clinical trial proposal has been submitted, outlining plans for a small-scale study aimed at facilitating regulatory discussions and potential approval in the event of favorable outcomes. The study is intended to involve a limited number of participants and is crucial for advancing the research in question.
